TheracosBio announced that Brenzavvy™, an FDA-approved oral sodium-glucose cotransporter 2 inhibitor, is now available by prescription through the Mark Cuban Cost Plus Drug Company, PBC.
TheracosBio announced that Brenzavvy™, an FDA-approved oral sodium-glucose cotransporter 2 inhibitor, is now available by prescription through the Mark Cuban Cost Plus Drug Company, PBC.